Skip to main content
. Author manuscript; available in PMC: 2016 Jun 2.
Published in final edited form as: AIDS Care. 2013 Nov 5;26(6):716–722. doi: 10.1080/09540121.2013.855700

Table 3.

Type of and reason for colorectal cancer screening, among patients with and without HIV who received colorectal cancer screening.*

HIV+ patients (N=8,213) HIV- patients (N=38,607) p-value
Screening Location, n (%)
 Inpatient 1091 (13.3%) 3310 (8.6%) <0.001
 Outpatient 7209 (87.8%) 35737 (92.6%) <0.001
 Inpatient and Outpatient 87 (1.1%) 440 (1.1%) 0.531
Procedure, n (%)
 Colonoscopy 6015 (86.0%) 29927 (86.7%) <0.001
 Sigmoidoscopy 680 (9.7%) 2475 (7.2%) <0.001
 Barium Enema 303 (4.3%) 2098 (6.1%) <0.001
*

Of patients included in the matched colorectal cancer screening dataset. Patients were matched on state, five-year age group, and gender. Relationships are considered statistically significant at a<0.05.

HIV=Human Immunodeficiency Virus